FRAXA funds research leading to treatments and a cure for Fragile X.
In 1991, Ben
Oostra, Stephen Warren, and David Nelson discovered
the gene for Fragile X, FMR1. FRAXA is
the name they gave the mutation on FMR1 which causes
Fragile X
Summary of Findings: What
do we know and how close are we to delivering treatments and a cure?
Research Reports:
All FRAXA grants, by year, are described here. Each FRAXA investigator has a page about his/her
project.
Applying for FRAXA Grants: FRAXA's research priorities, application information, renewal and final report guidelines.